Nombre del producto:Ethyl 3-oxopentanoate

IUPAC Name:ethyl 3-oxopentanoate

CAS:4949-44-4
Fórmula molecular:C7H12O3
Pureza:98%
Número de catálogo:CM253179
Peso molecular:144.17

Unidad de embalaje Stock disponible Precio($) Cantidad
CM253179-1000g in stock ȦƱȌ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :4949-44-4
Fórmula molecular:C7H12O3
Punto de fusión:-
Código de sonrisas:CCC(CC(OCC)=O)=O
Densidad:
Número de catálogo:CM253179
Peso molecular:144.17
Punto de ebullición:193°C at 760 mmHg
Nº Mdl:MFCD00009317
Almacenamiento:Keep in a tight container and store at ambient temperature,protect from light

Column Infos

VX-548
Vertex announced positive results from its Phase 2 dose-ranging study of VX-548 in people with painful diabetic peripheral neuropathy (DPN). VX-548 is an investigational oral, selective NaV1.8 inhibitor that is highly selective for NaV1.8 relative to other NaV channels. NaV1.8 is a voltage-gated sodium channel that plays a critical role in pain signaling in the peripheral nervous system. NaV1.8 is a genetically validated target for the treatment of pain. Vertex's strategy is to develop new drug types by selectively inhibiting NaV1.8. Compared to opioid drugs, they may provide better analgesic effects while avoiding side effects such as addiction. VX-548 has been granted Breakthrough Therapy and Fast Track designations in the U.S. for moderate to severe acute pain.